Cargando…
Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study
AIMS: Risk‐scoring systems for colorectal liver metastasis (CRLM) after hepatectomy allow prognoses to be predicted preoperatively. We investigated the clinical outcomes of neoadjuvant chemotherapy for resectable CRLM according to patient risk status, aiming to determine the subgroup of patients who...
Autores principales: | Noda, Takehiro, Takahashi, Hidekazu, Tei, Mitsuyoshi, Nishida, Naohiro, Hata, Taishi, Takeda, Yutaka, Ohue, Masayuki, Wada, Hiroshi, Mizushima, Tsunekazu, Asaoka, Tadafumi, Uemura, Mamoru, Kobayashi, Shogo, Murata, Kohei, Satoh, Taroh, Doki, Yuichiro, Eguchi, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154835/ https://www.ncbi.nlm.nih.gov/pubmed/37152774 http://dx.doi.org/10.1002/ags3.12631 |
Ejemplares similares
-
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer
por: Yukimoto, Ryohei, et al.
Publicado: (2021) -
Comprehensive profiling of novel epithelial–mesenchymal transition mediators and their clinical significance in colorectal cancer
por: Ishikawa, Satoshi, et al.
Publicado: (2021) -
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
por: Matsuda, Chu, et al.
Publicado: (2022) -
Impact of the COVID‐19 pandemic on colorectal cancer surgery in Japan: Clinical Study Group of Osaka University―A multicenter retrospective study
por: Miyo, Masaaki, et al.
Publicado: (2022) -
Administration Method of Adjuvant Tegafur‐Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study
por: Hata, Taishi, et al.
Publicado: (2021)